EUVIMEDSkopri EUVIMED
Crossref

Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL)

Senlin Hou, Ming Xiong, Binxian Xu, Duze Zhao, Zhinan Du, Dongjun Fu, Wei Lu, Junqing Hou, Weiguo Chen

Research journal · 2025 · 1 (1)

DOI: 10.65281/736336 ↗

At a glance

Journal article in Research journal, 2025. Written by Senlin Hou and 8 co-authors.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Ebda abstract disponibbli.

Cite

APA

Hou, S., Xiong, M., Xu, B., Zhao, D., Du, Z., Fu, D., Lu, W., Hou, J., & Chen, W. (2025). Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL). Research journal, 1(1). https://doi.org/10.65281/736336

Vancouver

Hou S, Xiong M, Xu B, Zhao D, Du Z, Fu D, et al. Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL). Research journal. 2025;1(1). doi:10.65281/736336

BibTeX
@article{Hou2025,
  author = {Hou, Senlin and Xiong, Ming and Xu, Binxian and Zhao, Duze and Du, Zhinan and Fu, Dongjun and Lu, Wei and Hou, Junqing and Chen, Weiguo},
  title = {Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL)},
  journal = {Research journal},
  year = {2025},
  volume = {1},
  number = {1},
  doi = {10.65281/736336}
}
Start for free →